in

National Open University of Nigeria (NOUN) to resume free virtual Class from May 4

The National Open University of Nigeria (NOUN) has concluded plan to officially resume her academic session on May 4th, 2020.

In a Statement by the School Management; the NOUN “in conjunction with CISCO Academy, to offer free virtual training programme on some selected digital short courses from May 4, to enhance academic activities.”

The Statement further said”

“Online Facilitation offers the opportunity for students to engage with facilitators on the course materials. Typically, the facilitation exercise comprises of three main activities:

1.      Video Conferencing Sessions: Here the facilitator will come online for one hour based on a predetermined schedule (see https://mylearningspace.nouedu2.net/info/time-table) . The facilitator will briefly explain concepts in a course module or unit under consideration after which he/she answers questions students may have on the course material. All the video conferencing session will be recorded and made available on the NOUN Learning Space for review and the benefit of those that could not join the sessions.

2.      Discussion Forums: An online discussion forum is a learning tool that gives students a place to express their opinion and understanding regarding the topic outlined for discussion. Students will be able to challenge one another to think deep on the course. The online facilitator will guide the process.

3.      Chat Sessions with other students in the course

“Students may participate in the activities using internet-enabled smart devices i.e. smartphones, tablets, laptops and desktops. Throughout the exercise students are expected to exhibit basic online etiquette.” The statement concluded.

What do you think?

Written by IJAM.ng

Leave a Reply

Your email address will not be published. Required fields are marked *

Air Task Force kills several terrorists in Borno State

Disclaimer: NAFDAC disassociates self from PAXHERBAL Advertorial on COVID-19 cure, says Agency has no approved any drug yet